Abstract: Reliable and accurate wind power prediction is fundamental for efficient operation of wind energy system. However, the stochasticity and volatility cause a lot of colored noises, making wind ...

Feb 10 (Reuters) - Microsoft is exploring using superconducting ‌power lines in its data centers, ‌which could potentially accelerate its massive U.S. build-out of the server warehouses by making them ...

Chevron CEO Mike Wirth detailed the company’s strategy to harness U.S. natural resources to meet soaring artificial intelligence power demand — without passing the cost along to consumers. "As data ...

Rachel is a freelancer based in Echo Park, Los Angeles and has been writing and producing content for nearly two decades on subjects ranging from tech to fashion, health and lifestyle to entertainment ...

This story was originally published by ProPublica. The Trump administration is planning to use artificial intelligence to write federal transportation regulations, according to U.S. Department of ...

The Trump administration is planning to use artificial intelligence to write federal transportation regulations, according to U.S. Department of Transportation records and interviews with six agency ...

Forbes contributors publish independent expert analyses and insights. Robin Ryan, a career counselor & author covers job search & careers. This voice experience is generated by AI. Learn more. This ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Trump administration's changes to the CFPB cost Americans $19B, a new report says Bad Bunny ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...